Hi all,
This I believe is a very good sign.
The previous patent we had for Kinase cancer was due to expire in 2033, with a probable extension to 2038 leaving us 12 year runway which was possibly too short for a BP partnership. Now with the combination patent we get 25 years.
Is it a game changer in the minds of those that are looking at our products, I will let you ponder.
Cheers Kpax.
Hi all,This I believe is a very good sign.The previous patent we...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |